Whole Shine Medical Technology Co., Ltd. Class A

Whole Shine Medical Technology Co., Ltd. Class A

SSZSE:002622
2.25
CNY
+0.01
(+0.45%)
1.74BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.22
0.19
0.18
0.15
0.24
0.46
0.19
0.14
0.2
0.6
0.9
1.03
0.84
- -
Basic EPS, GAAP
0.05
0.05
0.11
0.02
0.09
0.04
0.01
-0.35
-0.09
-0.31
-0.11
-0.04
-0.14
- -
Free Cash Flow per Basic Share
0.04
-0.08
-0.02
-0.05
-0.22
-0.01
0.03
0.08
0.02
0.01
0.12
0.09
0.05
- -
Dividend per Share
- -
0.01
0.2
- -
0.02
0.04
0.05
0.07
0.04
0.03
0.03
0.02
0.02
0.01
Book Value per Share
1.4
1.45
1.37
1.39
1.47
1.52
1.51
1.04
1.02
0.68
0.52
0.47
0.32
0.31
Tangible Book Value per Share
1.33
1.38
1.31
1.33
1.06
1.19
1.23
0.95
0.68
0.39
0.22
0.18
0.05
0.04
Basic Weighted Avg Shares
833
859
822
784
799
921
836
840
840
840
840
839
840
841
Sales/Revenue/Turnover
185
161
147
120
195
422
155
114
168
501
757
862
703
- -
Operating Margin (%)
8.52
9.4
5.91
-30.75
9.34
-1.84
1.12
11.56
2.16
-12.91
10.12
6.47
-2.63
- -
Depreciation Expense
12
11
12
15
18
20
14
188
16
63
64
64
56
- -
Net Income, GAAP
39
47
90
16
72
37
7
-297
-76
-257
-94
-38
-119
- -
Effective Tax Rate (%)
18.73
12.75
5.18
- -
10.04
40.9
41.12
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
20.94
29.34
61.68
13.05
36.89
8.72
4.79
-259.85
-45.2
-51.29
-12.47
-4.37
-16.99
- -
Working Capital
964
546
410
358
137
135
3
-58
-170
-548
-589
-591
-642
-631
LT Debt
3
2
2
2
200
99
- -
79
242
191
161
151
128
120
Total Equity
1,176
1,220
1,154
1,170
1,255
1,344
1,265
871
879
569
465
443
312
311
Return on Invested Capital (%)
2.93
3.54
6.58
- -
5.28
2.36
0.38
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
3.34
3.84
7.82
- -
5.91
3.43
1.77
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
3.34
3.94
7.61
1.35
5.97
2.93
0.58
-27.83
-8.78
-35.87
-18.77
-9.07
-35.71
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
323
322
320
LT Borrowings
- -
- -
- -
LT Finance Leases
128
126
120
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
840
840
840
Market Capitalization
2,495
2,318
1,739

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
262
257
257
Cash, Cash Equivalents & STI
137
136
139
Accounts Receivable, Net
25
21
18
Inventories
42
46
44
Total Current Liabilities
904
899
888
Payables & Accruals
- -
- -
- -
ST Debt
323
322
320
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-10.83%
-17.41%
-29.67%
Free Cash Flow
118.48%
193.84%
-43.85%
Net Income, GAAP
-368.84%
51.41%
216.85%
Sales/Revenue/Turnover
36.28%
58.29%
-18.42%
Total Cash Common Dividend
28.26%
-20.71%
-8.38%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
164
219
253
227
862
2025
143
171
- -
176
703
2026
135
179
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
0.01
0.02
-0.06
-0.04
2025
-0.01
-0.01
- -
-0.11
-0.14
2026
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
- -
- -
0.02
2025
- -
0.01
- -
- -
0.02
2026
- -
- -
- -
- -
- -

Company Description

CEO
Lu Lu
Full Time Employees
1,709
Sector
Producer manufacturing
Industry
Electrical products
Address
Building 1, Room 502 Beijing BE China 100025
IPO Date
Sep 30, 2011
Business
Whole Shine Medical Technology Co., Ltd. (002622.SZ) develops, manufactures, and sells medical devices focused on minimally invasive surgical solutions, including endoscopic systems, disposable endoscopic instruments, and related accessories. Its core product portfolio encompasses high-definition endoscopes such as gastroscopes, duodenoscopes, colonoscopes, and bronchoscopes; disposable devices like biopsy forceps, injection needles, snares, and retrieval nets; and supporting equipment including endoscopic processors, light sources, and insufflators. The company primarily serves hospitals, clinics, and medical institutions in the healthcare sector, with operations centered in China and expanding into international markets in Asia and beyond. Founded in 2006 and headquartered in Zhuhai, Guangdong Province, China, Whole Shine Medical operates through subsidiaries dedicated to research, production, and distribution, positioning it as a key player in China's endoscopy market. In recent developments, the company completed a strategic acquisition of a majority stake in a leading disposable endoscope accessories manufacturer in 2024, enhancing its production capacity and product diversification. It also launched new generations of 4K ultra-high-definition endoscopic systems and AI-assisted diagnostic tools in late 2024, aimed at improving procedural accuracy and efficiency. Additionally, Whole Shine Medical secured a significant funding round from institutional investors in early 2025 to support research and development in robotic-assisted endoscopy and global market expansion.